Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study

(1) Background: It is well-established that coronavirus disease-2019 (COVID-19) is highly pro-inflammatory, leading to activation of the coagulation cascade. COVID-19-induced hypercoagulability is associated with adverse outcomes and mortality. Current guidelines recommend that hospitalized COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Akinosoglou, Karolina, Savopoulos, Christos, Pouliakis, Abraham, Triantafyllidis, Charalampos, Markatis, Eleftherios, Golemi, Foteini, Liontos, Angelos, Vadala, Charikleia, Papanikolaou, Ilias C., Dimakopoulou, Vasiliki, Xarras, Panagiotis, Varela, Katerina, Kaiafa, Georgia, Mitsianis, Athanasios, Chatzistamati, Anastasia, Randou, Efthalia, Savvanis, Spyridon, Pavlaki, Maria, Efraimidis, Georgios, Samaras, Vasileios, Papazoglou, Dimitrios, Konstantinidou, Alexandra, Panagopoulos, Periklis, Milionis, Haralampos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027745/
https://www.ncbi.nlm.nih.gov/pubmed/35458497
http://dx.doi.org/10.3390/v14040767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027745/
https://www.ncbi.nlm.nih.gov/pubmed/35458497
http://dx.doi.org/10.3390/v14040767

Ejemplares similares